Sarepta therapeutics announces inaugural $600 million senior secured revolving credit facility

Cambridge, mass.--(business wire)--sarepta therapeutics, inc. (nasdaq:srpt), the leader in precision genetic medicine for rare diseases, announced today that it has closed on a $600 million senior secured revolving credit facility with a bank syndicate. "sarepta's financial strength and the positive outlook for our business provide us with the flexibility to use non-dilutive financing by establishing a revolving credit facility. it supplements our strong balance sheet and allows for contingent.
SRPT Ratings Summary
SRPT Quant Ranking